Effect Of Fluticasone Propionate/Salmeterol (250/50) On Arterial Stiffness In Patients With COPD

被引：0
|
作者：
Dransfield, M. T.
Cockcroft, J.
Townsend, R.
Coxson, H. O.
Sharma, S.
Rubin, D.
Emmett, A.
Cicale, M.
Crater, G.
Martinez, F. J.
机构：
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2011年 / 183卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2631
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Effect of fluticasone propionate/salmeterol on arterial stiffness in patients with COPD
    Dransfield, Mark T.
    Cockcroft, John R.
    Townsend, Raymond R.
    Coxson, Harvey O.
    Sharma, Sanjay S.
    Rubin, David B.
    Emmett, Amanda H.
    Cicale, Michael J.
    Crater, Glenn D.
    Martinez, Fernando J.
    RESPIRATORY MEDICINE, 2011, 105 (09) : 1322 - 1330
  • [2] Effect of fluticasone propionate/salmeterol (250/50 μg) or salmeterol (50 μg) on COPD exacerbations
    Ferguson, Gary T.
    Anzueto, Antonio
    Fei, Richard
    Emmett, Amanda
    Knobil, Katharine
    Kalberg, Christopher
    RESPIRATORY MEDICINE, 2008, 102 (08) : 1099 - 1108
  • [3] Effect of fluticasone propionate/salmeterol 250/50 on lung hyperinflation and exercise endurance in patients with COPD
    O'Donnell, DE
    Sciurba, F
    Celli, B
    Mahler, DA
    Webb, K
    Kalberg, C
    Crater, C
    Knobil, K
    CHEST, 2005, 128 (04) : 178S - 178S
  • [4] Effect of Fluticasone Propionate/Salmeterol (250/50) on COPD Exacerbations and Impact on Patient Outcomes
    Anzueto, Antonio
    Ferguson, Gary T.
    Feldman, Greg
    Chinsky, Kenneth
    Seibert, Allan
    Emmett, Amanda
    Knobil, Katharine
    O'Dell, Dianne
    Kalberg, Christopher
    Crater, Glenn
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2009, 6 (05) : 320 - 329
  • [5] Efficacy of Advair Diskus 250/50 (fluticasone propionate/salmeterol) in patients previously naive to COPD maintenance therapy
    Anzueto, AR
    Sense, W
    Yates, J
    Brown, C
    Knobil, K
    CHEST, 2004, 126 (04) : 808S - 808S
  • [6] Maintenance of bronchodilator response for Advair Diskus 250/50 (fluticasone propionate/salmeterol) but not ipratropium/albuterol in patients with COPD
    Knobil, K
    Kalberg, C
    Merchant, K
    Emmett, A
    Cicale, M
    CHEST, 2004, 126 (04) : 807S - 807S
  • [7] A randomized, double-blind trial comparing the effect of fluticasone/salmeterol 250/50 to salmeterol on COPD exacerbations in patients with COPD
    Ferguson, Gary
    Anzueto, Antonio
    Fei, Richard
    Emmett, Amanda
    Crater, Glenn
    Knobil, Kate
    Kalberg, Chris
    CHEST, 2007, 132 (04) : 530S - 531S
  • [8] The salmeterol/fluticasone propionate (50/250mcg) dry powder combination Diskus® has a faster onset of effect compared with salmeterol or fluticasone propionate in patients with asthma.
    Lumry, W
    Windom, H
    Mendelson, L
    Pedinoff, A
    Prillaman, B
    Baitinger, L
    Woodring, A
    House, K
    Shah, T
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (01) : S132 - S132
  • [9] Efficacy of Advair Diskus 250/50 (fluticasone propionate/salmeterol) or ipratropium/albuterol in patients with COPD associated with chronic bronchitis and/or emphysema
    Sciurba, FC
    Kalberg, C
    Emmett, A
    Merchant, K
    Brown, C
    Knobil, K
    CHEST, 2004, 126 (04) : 807S - 808S
  • [10] The efficacy and safety of fluticasone propionate (250 μg)/salmeterol (50 μg) combined in the diskus inhaler for the treatment of COPD
    Hanania, NA
    Darken, P
    Horstman, D
    Reisner, C
    Lee, B
    Davis, S
    Shah, T
    CHEST, 2003, 124 (03) : 834 - 843
12345